Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Insys Therapeutics enrolls first patient in phase II trial of canabidiol

Aug. 19, 2016

Promising phase III topline results for RBP-6000 monthly depot to treat opioid use disorder

Aug. 17, 2016

Embera Neurotherapeutics receives grant to continue development of drug for cocaine addition

July 27, 2016

Cerecor announces research grant for the development of CERC-501

July 27, 2016

Cerecor awarded grant from NIAAA

July 21, 2016

Addex Therapeutics reports positive results on ADX-71441

June 10, 2016

FDA awards fast track designation to Indivior's RBP-6000 buprenorphine monthly depot

May 27, 2016

FDA approves Probuphine for opioid dependence

May 27, 2016

Cerecor awarded NIDA grant

April 12, 2016

XT-150 as a potential solution for opioid abuse crisis

April 4, 2016

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...